Ladenburg Thalmann Financial Services’s Timber Pharmaceuticals, Inc. TMBR Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio TMBR Stock Details TMBR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-3	Closed	-$1K	–	5585
2019 Q3	$1K	Hold	3	–	–	﹤0.01%	5199
2019 Q2	$1K	Hold	3	–	–	﹤0.01%	5196
2019 Q1	$4K	Hold	3	–	–	﹤0.01%	4778
2018 Q4	$5K	Sell	3 -1	-25%	-$2.37K	﹤0.01%	4630
2018 Q3	$12K	Hold	4	–	–	﹤0.01%	4205
2018 Q2	$15K	Hold	4	–	–	﹤0.01%	4019
2018 Q1	$15K	Hold	4	–	–	﹤0.01%	4019
2017 Q4	$7K	Buy	4 +3	+300%	+$8.18K	﹤0.01%	4403
2017 Q3	$6K	Hold	1	–	–	﹤0.01%	4345
2017 Q2	$11K	Hold	1	–	–	﹤0.01%	3973
2017 Q1	$6K	Hold	1	–	–	﹤0.01%	4258
2016 Q4	$4K	Hold	1	–	–	﹤0.01%	4353
2016 Q3	$6K	Hold	1	–	–	﹤0.01%	4101
2016 Q2	$7K	Hold	1	–	–	﹤0.01%	3988
2016 Q1	$12K	Buy	+1	New	+$22.6K	﹤0.01%	3610

Other funds holding TMBR

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

NFG

Norris Financial Group Greenville, South Carolina $251M AUM 48.4% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Ladenburg Thalmann Financial Services's TMBR Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services sold out of Timber Pharmaceuticals, Inc. (TMBR) in Q4 2019, closing a stake of 3 shares — an estimated $1K sold.

Ladenburg Thalmann Financial Services first reported a position in TMBR in Q1 2016 and held it in 15 quarters. The position peaked at $15K in Q2 2018. 7 funds tracked by Wall St. Rank hold TMBR as of Q4 2019.

Ladenburg Thalmann Financial Services reported no remaining Timber Pharmaceuticals, Inc. position as of Q4 2019 after selling out during the quarter.
Ladenburg Thalmann Financial Services sold 3 Timber Pharmaceuticals, Inc. shares in Q4 2019, an estimated $1K.
Ladenburg Thalmann Financial Services first reported a position in Timber Pharmaceuticals, Inc. in Q1 2016 and held it in 15 quarters.
Ladenburg Thalmann Financial Services's Timber Pharmaceuticals, Inc. position peaked at $15K in Q2 2018.
7 funds tracked by Wall St. Rank held Timber Pharmaceuticals, Inc. as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.